Body mass index reduction improves the baseline procoagulant imbalance of obese subjects

Area of Science:

• Cardiovascular Science
• Hematology
• Metabolic Disorders

Background:

• Obesity is a significant risk factor for cardiovascular diseases, often linked to hypercoagulability.
• Current understanding of obesity-associated hypercoagulability relies on limited traditional coagulation tests.
• There is a need for more comprehensive methods to assess in vivo coagulation in obese individuals.

Purpose of the Study:

• To investigate hypercoagulability in obese subjects using advanced thrombin generation assays.
• To evaluate the impact of endoscopic balloon placement on BMI and thrombin generation parameters.
• To establish the relationship between weight loss and coagulation status in obesity.

Main Methods:

• Investigated plasma from 33 obese subjects before and after endoscopic balloon placement (6 months).
• Utilized thrombin generation procedures to assess in vivo coagulation dynamics.
• Measured key thrombin generation parameters including endogenous thrombin potential (ETP), lag-time, peak-thrombin, time-to-peak, and velocity index.

Main Results:

• Obese subjects demonstrated significant hypercoagulability at baseline, evidenced by elevated ETP compared to controls.
• Endoscopic balloon placement led to a significant reduction in Body Mass Index (BMI).
• Post-procedure, thrombin generation parameters, including ETP, significantly decreased, indicating reduced hypercoagulability.

Conclusions:

• Obesity is associated with a prothrombotic state characterized by altered thrombin generation.
• Endoscopic balloon placement effectively reduces BMI and concurrently ameliorates hypercoagulability in obese patients.
• Thrombin generation assays provide valuable insights into the hemostatic changes associated with obesity and weight loss.